Literature DB >> 27221522

Current status of pediatric renal transplant pathology.

Jan U Becker1.   

Abstract

Histopathology is still an indispensable tool for the diagnosis of kidney transplant dysfunction in adult and pediatric patients. This review presents consolidated knowledge, recent developments and future prospects on the biopsy procedure, the diagnostic work-up, classification schemes, the histopathology of rejection, including antibody-mediated forms, ABO-incompatible transplants, protocol biopsies, recurrent and de novo disease, post-transplant lymphoproliferative disorder, infectious complications and drug-induced toxicity. It is acknowledged that frequently the correct diagnosis can only be reached in consensus with clinical, serological, immunogenetical, bacteriological and virological findings. This review shall enhance the understanding of the pediatric nephrologist for the thought processes of nephropathologists with the aim to facilitate teamwork between these specialist groups for the benefit of the patient.

Entities:  

Keywords:  ABMR; Allograft; Biopsy; Nephropathology; Rejection; TCMR

Mesh:

Year:  2016        PMID: 27221522     DOI: 10.1007/s00467-016-3381-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  85 in total

1.  IgA nephropathy recurs early in the graft when assessed by protocol biopsy.

Authors:  Fernanda Ortiz; Rosana Gelpi; Petri Koskinen; Anna Manonelles; Anne Räisänen-Sokolowski; Marta Carrera; Eero Honkanen; Josep M Grinyó; Josep M Cruzado
Journal:  Nephrol Dial Transplant       Date:  2011-12-13       Impact factor: 5.992

2.  A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.

Authors:  B Sis; G S Jhangri; J Riopel; J Chang; D G de Freitas; L Hidalgo; M Mengel; A Matas; P F Halloran
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

3.  Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts.

Authors:  James Gough; David Rush; John Jeffery; Peter Nickerson; Rachel McKenna; Kim Solez; Kiril Trpkov
Journal:  Nephrol Dial Transplant       Date:  2002-06       Impact factor: 5.992

4.  Glomerular c4d immunoreactivity in acute rejection biopsies of renal transplant patients.

Authors:  M Valente; L Furian; M Della Barbera; C Silvestre; S Marino; M Seveso; E Cozzi; P Rigotti; F B Aiello
Journal:  Transplant Proc       Date:  2012-09       Impact factor: 1.066

5.  Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study.

Authors:  B Iványi; H Fahmy; H Brown; P Szenohradszky; P F Halloran; K Solez
Journal:  Hum Pathol       Date:  2000-09       Impact factor: 3.466

6.  Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Authors:  B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi
Journal:  Am J Transplant       Date:  2010-01-29       Impact factor: 8.086

7.  Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Authors:  Anne-Laure Sellier-Leclerc; Veronique Fremeaux-Bacchi; Marie-Agnès Dragon-Durey; Marie-Alice Macher; Patrick Niaudet; Geneviève Guest; Bernard Boudailliez; François Bouissou; Georges Deschenes; Sophie Gie; Michel Tsimaratos; Michel Fischbach; Denis Morin; Hubert Nivet; Corinne Alberti; Chantal Loirat
Journal:  J Am Soc Nephrol       Date:  2007-06-28       Impact factor: 10.121

8.  Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.

Authors:  B Ryffel; E Weber; M J Mihatsch
Journal:  Exp Nephrol       Date:  1994 Nov-Dec

9.  A position paper on standardizing the nonneoplastic kidney biopsy report.

Authors:  Anthony Chang; Ian W Gibson; Arthur H Cohen; Jan W Weening; J Charles Jennette; Agnes B Fogo
Journal:  Hum Pathol       Date:  2012-07-12       Impact factor: 3.466

10.  Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Authors:  M Haas; B Sis; L C Racusen; K Solez; D Glotz; R B Colvin; M C R Castro; D S R David; E David-Neto; S M Bagnasco; L C Cendales; L D Cornell; A J Demetris; C B Drachenberg; C F Farver; A B Farris; I W Gibson; E Kraus; H Liapis; A Loupy; V Nickeleit; P Randhawa; E R Rodriguez; D Rush; R N Smith; C D Tan; W D Wallace; M Mengel
Journal:  Am J Transplant       Date:  2014-02       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.